Sun Pharma looks to tame the dragon; ties up with China Medical Systems

Sun Pharma has entered into an exclusive licencing agreement with China Medical System Holdings (CMSH) to develop and commercialise seven generic products in Mainland China.

Sun Pharma reports Q1 net profit at Rs 1,387 crore

Sun Pharmaceutical on Tuesday reported a net profit of Rs 1,387 crore in the April to June quarter of 2019-20, up 31 per cent in the year-on period.